Immediate Impact
8 from Science/Nature 71 standout
Citing Papers
Pancreatic cancer
2020 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Works of J.-F. Bosset being referenced
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
2008
Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: A FFCD-SFRO study
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| J.-F. Bosset | 1602 | 689 | 688 | 43 | 1.9k | |
| Stefano Cordio | 1777 | 861 | 683 | 74 | 2.1k | |
| Roger K.C. Ngan | 923 | 805 | 477 | 43 | 2.0k | |
| A. Crellin | 981 | 793 | 819 | 46 | 1.7k | |
| Salvatore Artale | 1846 | 762 | 630 | 40 | 2.2k | |
| Jill N. Allen | 1719 | 984 | 912 | 108 | 2.3k | |
| Ryan T. Groeschl | 835 | 869 | 646 | 45 | 1.6k | |
| Mukund S. Didolkar | 941 | 580 | 656 | 59 | 1.8k | |
| Pierre-Luc Etienne | 2177 | 1622 | 1397 | 72 | 3.1k | |
| Jason Klapman | 1198 | 984 | 774 | 75 | 1.8k | |
| R. Adam | 877 | 600 | 427 | 25 | 1.6k |
All Works
Loading papers...